Literature DB >> 24434023

The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor.

Tian-zhu Liu1, Xin Wang1, Yi-feng Bai2, Hong-zhan Liao1, Sheng-cong Qiu1, Ye-qing Yang3, Xiao-Hui Yan4, Jian Chen1, Hong-bo Guo5, Shi-zhong Zhang6.   

Abstract

Glioblastomas are lethal tumors characterized by malignant proliferation and recurrence promoted partly by glioblastoma stem cells (GSCs). GSCs are known to be regulated by hypoxia, but the mechanisms involved in this regulation are not fully understood. We now demonstrate that hypoxia-inducible factor HIF2α and prostatic acid phosphatase (PAP) are preferentially expressed in hypoxic GSCs in comparison with non-stem tumor cells and normal neural stem cells and that PAP is regulated by HIF2α. Targeting PAP in hypoxic GSCs inhibits self-renewal and proliferation in vitro and attenuates tumor initiation potential of GSCs in vivo. Using specific adenosine receptor antagonists, we further find that the pro-proliferative role of PAP is stemmed from stimulated A2B adenosine receptors. Moreover, selective blockage of A2B receptor or knockdown of PAP or A2B on hypoxic GSCs results in significant reduction of phosphorylation of Akt and Erk-1/2. Our results demonstrate that PAP may play a pro-proliferative role in hypoxic GSCs with a HIF2α-induction pattern, which may be ascribed to stimulated A2B receptors and activated Akt and Erk-1/2 pathways. Therefore, we propose that these identified molecular regulators of GSCs in the hypoxic niche might represent promising targets for antiglioblastoma therapies. Crown
Copyright © 2014. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A2B receptors; Adenosine; Glioblastoma stem cells; Hypoxia; Prostatic acid phosphatase

Mesh:

Substances:

Year:  2014        PMID: 24434023     DOI: 10.1016/j.biocel.2014.01.007

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

1.  CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling.

Authors:  Angela Yan; Michelle L Joachims; Linda F Thompson; Andrew D Miller; Peter D Canoll; Margaret S Bynoe
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

Review 2.  The adenosine pathway in immuno-oncology.

Authors:  Bertrand Allard; David Allard; Laurence Buisseret; John Stagg
Journal:  Nat Rev Clin Oncol       Date:  2020-06-08       Impact factor: 66.675

Review 3.  Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches.

Authors:  Elizabeth A Thompson; Jonathan D Powell
Journal:  Annu Rev Med       Date:  2020-09-09       Impact factor: 13.739

4.  Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells.

Authors:  Angelo Torres; Yosselyn Vargas; Daniel Uribe; Catherine Jaramillo; Alejandra Gleisner; Flavio Salazar-Onfray; Mercedes N López; Rómulo Melo; Carlos Oyarzún; Rody San Martín; Claudia Quezada
Journal:  Oncotarget       Date:  2016-10-11

5.  Cancer Stem Cells: Emergent Nature of Tumor Emergency.

Authors:  Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev
Journal:  Front Genet       Date:  2018-11-16       Impact factor: 4.599

6.  Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.

Authors:  Sebastián Alarcón; María de Los Ángeles Toro; Carolina Villarreal; Rómulo Melo; Rodrigo Fernández; Angel Ayuso Sacido; Daniel Uribe; Rody San Martín; Claudia Quezada
Journal:  Cells       Date:  2020-08-18       Impact factor: 6.600

Review 7.  The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment.

Authors:  Asieh Emami Nejad; Simin Najafgholian; Alireza Rostami; Alireza Sistani; Samaneh Shojaeifar; Mojgan Esparvarinha; Reza Nedaeinia; Shaghayegh Haghjooy Javanmard; Marjan Taherian; Mojtaba Ahmadlou; Rasoul Salehi; Bahman Sadeghi; Mostafa Manian
Journal:  Cancer Cell Int       Date:  2021-01-20       Impact factor: 5.722

Review 8.  Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?

Authors:  Jana Kotulová; Marián Hajdúch; Petr Džubák
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

9.  Adenosine Depletion as A New Strategy to Decrease Glioblastoma Stem-Like Cells Aggressiveness.

Authors:  Ignacio Niechi; Atenea Uribe-Ojeda; José Ignacio Erices; Ángelo Torres; Daniel Uribe; José Dellis Rocha; Pamela Silva; Hans G Richter; Rody San Martín; Claudia Quezada
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

Review 10.  A2B Adenosine Receptor and Cancer.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.